Rare diseases
Investigational molecules
Locations
Via Antonio Meucci 3, 20091, Italy
Newron Pharmaceuticals S.p.A. is active in psychiatric research with a clear focus on treatment-resistant schizophrenia, an area of high unmet clinical need within severe mental health disorders.
The sponsor’s clinical work in this field centers on patients whose symptoms remain difficult to manage despite ongoing antipsychotic treatment.
Newron Pharmaceuticals S.p.A. runs clinical trials in conditions such as Schizophrenia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
